news

Scientists initiate first ethical guidelines for organs cultivated in vitro

Organ models, which are cultivated in the laboratory from human stem cells and grow into living tissue, are one of the most important scientific breakthroughs of recent years.

Jürgen Knoblich, a leading authority on stem cells and deputy director of the IMBA (Institute for Molecular Biotechnology of the Austrian Academy of Sciences), together with international experts, presents a first ethical guideline for research into human organ models. He argues for critical and responsible engagement with the new technology.

In vitro organs

Scientists, patients and the wider public have high hopes for this emerging field of research, as so-called “organoids” have a huge potential in terms of research and modern medicine. In-vitro organ models allow complex organ development studies and pathogenetic analyses to be carried out directly in human tissue.

New substances and therapies can be tested on human material much more quickly using this technology. Regenerative medical practice could conceivably cultivate the required tissue in the laboratory from the cells of a patient and, lessen dependency on organ donations.

 

Reserve your FREE place

 


Are you looking to optimise antibody leads in your drug discovery? Register for this webinar to find out how!

30 July 2025 | 10:00 AM BST | FREE Webinar

Join this webinar to hear from Dr. Lei Guo as she shares how early insights into liability, PK, stability, and manufacturability can help you optimise antibody leads in early drug discovery – and mitigate downstream risks later in development.

What You’ll Learn:

  • How to assess key developability risks early
  • How in silico modelling and in vitro testing can be combined to predict CMC risks earlier in discovery stage
  • How micro-developability strategies are tailored for complex or novel formats

Don’t miss your chance to learn from real-world leaders

Register Now – It’s Free!

 

No more animal testing

The use of organoids could also significantly reduce the need for animal experiments, although biologists believe these cannot be completely eliminated in the foreseeable future.

Organoids – high hopes and bioethical dilemmas

From an ethical perspective, this new technology raises a whole range of issues. These include important caveats in relation to the use of human embryonic stem cells or the application of gene therapies to prevent or treat diseases.

Jürgen Knoblich believes that “the development of organoids is unexplored scientific territory. As a researcher, I am fascinated by the huge potential of this technology. However, I also believe it’s my job to actively promote dialogue around responsible research and to engage the wider public in the discussion”.

In 2013, the stem cell specialist made scientific headlines worldwide with his laboratory-cultivated brain models. In the latest policy statement issued in collaboration with the immunologist and geneticist Hans Clevers and the bioethicist and Member of the Dutch Parliament, Annelien Bredenoord, the researchers also examined for the first time the most important ethical dimensions of organoid research.

According to Knoblich, “we hope that our work has created a solid foundation for the establishment of framework conditions for responsible engagement with this new technology”.

Leave a Reply

Your email address will not be published. Required fields are marked *